Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices 14275 

Dated: March 3, 2022. 

Lauren K. Roth, 

Associate Commissioner for Policy. 

[FR Doc. 2022–05310 Filed 3–11–22; 8:45 am] 

BILLING CODE 4164–01–C 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Committee on Vital and Health 

Statistics 

AGENCY: Centers for Disease Control and 

Prevention. 

ACTION: Notice of meeting. 

SUMMARY: Pursuant to the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) announces the following 

advisory committee meeting. This 

meeting is open to the public. The 

public is welcome to obtain the link to 

attend this meeting by following the 

instructions posted on the Committee 

website: https://ncvhs.hhs.gov/ 

meetings/full-committee-meeting-10/. 

Name: National Committee on Vital 

and Health Statistics (NCVHS), Meeting 

of the full Committee. 

DATES: The meeting will be held 

Wednesday, March 30, 2022: 11:00 

a.m.–3:00 p.m. EST. 

ADDRESSES: Virtual open meeting. 

FOR FURTHER INFORMATION CONTACT: 

Substantive program information may 

be obtained from Rebecca Hines, MHS, 

Executive Secretary, NCVHS, National 

Center for Health Statistics, Centers for 

Disease Control and Prevention, 3311 

Toledo Road, Hyattsville, Maryland 

20782, or via electronic mail to vgh4@

cdc.gov; or by telephone (301) 458– 

4715. Summaries of meetings and a 

roster of Committee members are 

available on the home page of the 


jspears on DSK121TN23PROD with NOTICES1EN14MR22.001</GPH>
14276 Federal Register / Vol. 87, No. 49 / Monday, March 14, 2022 / Notices 

1Public Law 104–191, 110 Stat. 1936 (Aug 21, 

1996), available at https://www.congress.gov/104/ 

plaws/publ191/PLAW-104publ191.pdf. 

NCVHS website, https://ncvhs.hhs.gov/, 

where further information including an 

agenda and instructions to access the 

broadcast of the meeting will be posted. 

Should you require reasonable 

accommodation, please contact the CDC 

Office of Equal Employment 

Opportunity on (770) 488–3210 as soon 

as possible. 

SUPPLEMENTARY INFORMATION: 

Purpose: As outlined in its Charter, 

the National Committee on Vital and 

Health Statistics assists and advises the 

Secretary of HHS on health data, data 

standards, statistics, privacy, national 

health information policy, and the 

Department’s strategy to best address 

those issues. This includes the adoption 

and implementation of transaction 

standards, unique identifiers, operating 

rules and code sets adopted under the 

Health Insurance and Portability Act of 

1996 (HIPAA).1

At this meeting, the Committee will 

discuss two letters for approval, each 

containing a set of recommendations for 

HHS action. The first set conveys 

recommendations regarding privacy, 

confidentiality, and security 

considerations for data collection and 

use during a public health emergency. 

The second set conveys 

recommendations regarding standards 

for prior authorization, attachments, and 

HIPAA-designated transactions in 

general to support the goal to improve 

data sharing among patients, providers, 

payers, public health systems, and other 

actors in health care. 

The Committee will reserve time for 

public comment toward the end of the 

agenda. Meeting times and topics are 

subject to change. Please refer to the 

agenda posted at the NCVHS website for 

this meeting at: https://ncvhs.hhs.gov/ 

meetings/full-committee-meeting-10/ for 

updates. 

Sharon Arnold, 

Associate Deputy Assistant Secretary, Science 

and Data Policy, Office of the Assistant 

Secretary for Planning and Evaluation. 

[FR Doc. 2022–05289 Filed 3–11–22; 8:45 am] 

BILLING CODE 4150–05–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Child Health and Human Development 

Special Emphasis Panel; Contraception 

Development Research Center Program (P50 

Clinical Trial Optional). 

Date: March 23, 2022. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institutes of Health, 

6710B Rockledge Drive, Room 2125B, 

Bethesda, MD 20892–7002 (Video Assisted 

Meeting). 

Contact Person: Derek J. McLean, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Eunice Kennedy Shriver National 

Institute of Child Health and Human 

Development, National Institute Health, 

6710B Rockledge Drive, Room 2125B, 

Bethesda, MD 20892–7002, Derek.McLean@

nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to scheduling 

conflicts. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; National Institutes of Health, HHS) 

Dated: March 9, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05330 Filed 3–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Diabetes and 

Digestive and Kidney Diseases; Notice 

of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Diabetes and Digestive and Kidney Diseases 

Special Emphasis Panel; PAR19–202 High 

Impact, Interdisciplinary Science in NIDDK 

Research Areas: Hematology (RC2). 

Date: April 5, 2022. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: NIDDK, NIH, 6707 Democracy Blvd., 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ann A. Jerkins, Ph.D., 

Scientific Review Officer, Review Branch, 

DEA, NIDDK, National Institutes of Health, 

Room 7119, 6707 Democracy Boulevard, 

Bethesda, MD 20892–5452, 301–594–2242, 

jerkinsa@niddk.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.847, Diabetes, 

Endocrinology and Metabolic Research; 

93.848, Digestive Diseases and Nutrition 

Research; 93.849, Kidney Diseases, Urology 

and Hematology Research, National Institutes 

of Health, HHS) 

Dated: March 8, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–05284 Filed 3–11–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 


jspears on DSK121TN23PROD with NOTICES1